Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome

Transplantation

Volumn 58, Issue 4, 1994, Pages 443-446

  Opelz, Gerhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; STEROID;

ARTICLE; DOSE RESPONSE; DRUG MIXTURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AZATHIOPRINE; COMPARATIVE STUDY; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; RETROSPECTIVE STUDIES; STEROIDS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0028022638     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199408270-00009     Document Type: Article

References (27)

1. Simmons RL, Canafax DM, Strand M, et al. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Transplant Proc 1985; 17 (suppl 1): 266.
2. Paul LC. Maintenance immunosuppression: cyclosporine. In Milford EL, ed. Renal transplantation. New York: Churchill Livingstone 1989; 105.
3. Linder R, Lindholm A, Restifo A, Duraj F, Groth C-G. Long-term renal allograft function under maintenance immunosuppression with cyclosporine A or azathioprine. Transplant Int 1991; 4: 166.
4. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclo-sporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699.
5. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725.
6. Seale JP, Compton MR. Side-effects of corticosteroid agents. Med J Aust 1986; 144: 139.
7. Lawson DH, Lovatt GE, Gurton CS, Hennings RC. Adverse ef fects of azathioprine. Adverse Drug React Acute Poison Rev 1984; 3: 161.
8. Walker RG, d'Apice AJF. Azathioprine and steroids. In Morris PJ, ed. Kidney transplantation: principles and practice. Philadelphia: Saunders, 1988: 319.
9. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23: 1101.
10. Sheil AG, Disney AP, Mathew TG, Amiss N, Excell L. Malig nancy following renal transplantation. Transplant Proc 1992; 24: 1946.
11. Morris PJ, French ME, Dunnhill MS, et al. A controlled trial of cyclosporin in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation 1983; 36: 273.
12. Spielberger M, Aigner F, Schmid T, Bösmüller C, Königsrainer A, Margreiter R. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial. Transplant Proc 1988; 20: 169.
13. Watson MA, Briggs JD, Junor BJR, et al. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation. Transplant Proc 1989; 21: 1583.
14. Cristinelli L, Brunori G, Setti G, et al. Withdrawal of methyl-prednisolone at the sixth month in renal transplant recipients treated with cyclosporine. Transplant Proc 1987; 19: 2021.
15. Lloveras J, Masramon J, Orfila A, Cuevas X, Aubia J. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions. Transplant Proc 1987; 19: 2027.
16. Hillebrand G, Krumme D, Schleibner S, Land W, Gurland HJ. Is withdrawal of steroids hazardous in cadaveric renal transplants under treatment with cyclosporine? Transplant Proc 1988; 20: 126.
17. O'Connell PJ, d'Apice AJF, Walker RG, Francis DMA, Clunie GJA, Kincaid-Smith P. Results of steroid withdrawal in renal allograft recipients on low-dose cyclosporine A, azathioprine and prednisolone. Clin Transplant 1988; 2: 102.
18. Schulak JA, Mayes JT, Moritz CE, Hricik DE. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients. Transplantation 1990; 49: 327.
19. Isoniemi H, Eklund B, Hoeckerstedt K, et al. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results. Transplant Proc 1990; 22: 1365.
20. Gulanikar AC, Belitsky P, MacDonald AS, Cohen A, Bitter-Suermann H. Randomized controlled trial of steroids versus no steroids in stable cyclosporine-treated renal graft recipients. Transplant Proc 1991; 23: 990.
21. Tamm M, Thiel G, Huser B, Brunner FP, Mihatsch M, Landmann J. Cyclosporine monotherapy after kidney transplantation since 1983. Transplant Proc 1991; 23: 997.
22. Kiparski A, Frei D, Fierz W, et al. Immunologic monitoring of steroid withdrawal in renal allograft recipients on triple therapy with cyclosporine A, azathioprine and prednisone. Clin Transplantation 1990; 4: 153.
23. Kahan BD, Kerman RH, van Buren CT, Flechner SM, Golden DL, Lewis RM. Clinical outcome in 36 patients after at least one and up to 5 years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor. Transplant Proc 1989; 21: 1579.
24. Goulmy E, Bittner K, Blokland E, et al. Renal transplant pa tients with steroid withdrawal evaluated longitudinally for their donor-specific cytotoxic T cell reactivity. Transplantation 1991; 52: 1983.
25. Collaborative Transplant Study, University of Heidelberg, Newsletter 4, November 1992.
26. Hricik DE, Whalen CC, Lautman J, et al. Withdrawal of steroids after renal transplantation-clinical predictors of outcome. Transplantation 1992; 53: 41.
27. Thiel G, Fellmann T, Rosman J, Bock A, Landmann J, Mihatsch M. Long-term safety profile of sandimmune in renal transplantation. Transplant Proc 1992; 24 (suppl 2): 71.